The use of JAK vs TNF inhibitors shows no significant increase in the incidence of major adverse cardiovascular events in ...

Worries that tumor necrosis factor (TNF) inhibitors may exacerbate or even cause lung disease in patients with rheumatoid ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Neuroimmune modulation represents a promising treatment strategy that uses vagus nerve stimulation to reduce inflammation in ...

A new study finds that specific B-cell subsets at diagnosis may help predict remission in early rheumatoid arthritis, ...

[20] The current indication in the USA for this newly approved therapy is for active RA patients who have failed at least one TNF inhibitor. It is a monthly infusion, lasting approximately 1 h ...

Disease activity during pregnancy remained stable among the majority of women with RA or SpA, though relapses requiring treatment intensification were not uncommon.

Rheumatoid arthritis (RA) patients in Denmark with a ... results were similar when the group looked specifically at tumor necrosis factor (TNF) inhibitors (HR 1.10, 95% CI 0.21-3.16) and the ...

Sanofi’s development of an oral spin on Humira’s mechanism has hit a setback. | Sanofi’s development of an oral spin on ...

Tocilizumab has emerged as a key treatment for rheumatoid arthritis, showing efficacy, safety, and potential cardiovascular ...

An increased risk of both invasive and superficial fungal infections was observed among patients who received TNF-α inhibitors for various conditions.